Patent assignee · US · COMPANY

Hypnion, Inc.

14Patents
9Active
14Granted
39Portfolio score

Filing activity: Oct 16, 2002 → Mar 25, 2009 · 9 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US7355042B2 Treatment of CNS disorders using CNS target modulators Chemistry; Metallurgy 35 Expired
US7494998B2 Benzisoxazole piperazine compounds and methods of use thereof Chemistry; Metallurgy 4 Active
US7524864B2 Methods of treating sleep disorders Chemistry; Metallurgy 3 Active
US7563785B2 Quetiapine analogs and methods of use thereof Emerging Cross-Sectional Technologies 3 Active
US7317026B2 CNS target modulators Chemistry; Metallurgy 2 Expired
US7326721B2 Doxepin analogs and methods of use thereof Human Necessities 2 Expired
US7592333B2 Loxapine analogs and methods of use thereof Emerging Cross-Sectional Technologies 2 Active
US7807828B2 Olanzapine analogs and methods of use thereof Human Necessities 2 Active
US7482460B2 Doxepin analogs and methods of use thereof Human Necessities 1 Active
US7189757B2 Treatment of sleep disorders using CNS target modulators Chemistry; Metallurgy 1 Expired
US8101596B2 Loxapine analogs and methods of use thereof Emerging Cross-Sectional Technologies 0 Active
US8129410B2 Benzisoxazole piperidine compounds and methods of use thereof Chemistry; Metallurgy 0 Active
US8088778B2 Benzisoxazole piperazine compounds and methods of use thereof Chemistry; Metallurgy 0 Active
US7411069B2 Doxepin analogs and methods of use thereof Human Necessities 0 Expired

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.